• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛癌分析原发性和转移性癌症中的脂质代谢改变。

A pan-cancer analysis of lipid metabolic alterations in primary and metastatic cancers.

机构信息

School of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, China.

Inner Mongolia Key Laboratory of Functional Genomics and Bioinformatics, Inner Mongolia University of Science and Technology, Baotou, China.

出版信息

Sci Rep. 2023 Aug 23;13(1):13810. doi: 10.1038/s41598-023-41107-3.

DOI:10.1038/s41598-023-41107-3
PMID:37612422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10447541/
Abstract

Metabolic reprogramming is a hallmark of cancers, but pan-cancer level roles of lipid metabolism in cancer development are remains poorly understood. We investigated the possible roles of lipid metabolic genes (LMGs) in 14 cancer types. The results indicate that: (1) there is strong evidence for increased lipid metabolism in THCA and KICH. (2) Although the overall levels of lipid metabolic processes are down-regulated in some cancer types, fatty acid synthase activity and fatty acid elongation are moderately up-regulated in more than half of the cancer types. Cholesterol synthesis is up-regulated in five cancers including KICH, BLCA, COAD, BRCA, UCEC, and THCA. (3) The catabolism of cholesterols, triglycerides and fatty acids is repressed in most cancers, but a specific form of lipid degradation, lipophagy, is activated in THCA and KICH. (4) Lipid storage is enhanced in in kidney cancers and thyroid cancer. (5) Similarly to primary tumors, metastatic tumors tend to up-regulate biosynthetic processes of diverse lipids, but down-regulate lipid catabolic processes, except lipophagy. (6) The frequently mutated lipid metabolic genes are not key LMGs. (7) We established a LMG-based model for predicting cancer prognosis. Our results are helpful in expanding our understanding of the role of lipid metabolism in cancer.

摘要

代谢重编程是癌症的一个标志,但脂质代谢在癌症发生发展中的泛癌水平作用仍知之甚少。我们研究了脂质代谢基因(LMGs)在 14 种癌症类型中的可能作用。结果表明:(1)在 THCA 和 KICH 中,脂质代谢明显增强,有强有力的证据支持。(2)尽管某些癌症类型中脂质代谢过程的总体水平下调,但脂肪酸合成酶活性和脂肪酸延长在一半以上的癌症类型中中度上调。胆固醇合成在包括 KICH、BLCA、COAD、BRCA、UCEC 和 THCA 在内的五种癌症中上调。(3)在大多数癌症中,胆固醇、甘油三酯和脂肪酸的分解代谢受到抑制,但在 THCA 和 KICH 中,一种特定形式的脂质降解,即脂自噬被激活。(4)在肾癌和甲状腺癌中,脂质储存增强。(5)与原发性肿瘤相似,转移性肿瘤倾向于上调多种脂质的生物合成过程,但下调脂质分解代谢过程,脂自噬除外。(6)频繁突变的脂质代谢基因不是关键的 LMGs。(7)我们建立了一个基于 LMG 的模型来预测癌症预后。我们的结果有助于扩大对脂质代谢在癌症中的作用的理解。

相似文献

1
A pan-cancer analysis of lipid metabolic alterations in primary and metastatic cancers.泛癌分析原发性和转移性癌症中的脂质代谢改变。
Sci Rep. 2023 Aug 23;13(1):13810. doi: 10.1038/s41598-023-41107-3.
2
Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.多组学数据解析泛癌中脂质代谢失调及其对免疫微环境的影响。
BMC Bioinformatics. 2019 May 1;20(Suppl 7):195. doi: 10.1186/s12859-019-2734-4.
3
The pan-cancer landscape of glutamate and glutamine metabolism: A comprehensive bioinformatic analysis across 32 solid cancer types.泛癌种中谷氨酸和谷氨酰胺代谢全景分析:跨越 32 种实体瘤的全面生物信息学分析。
Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166982. doi: 10.1016/j.bbadis.2023.166982. Epub 2023 Dec 6.
4
The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders.脂噬作用(一种选择性自噬形式)在代谢紊乱中的调节、功能和作用。
Cell Death Dis. 2022 Feb 8;13(2):132. doi: 10.1038/s41419-022-04593-3.
5
Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming.脂联素通过脂肪酸代谢重编程触发乳腺癌细胞死亡。
J Exp Clin Cancer Res. 2022 Jan 5;41(1):9. doi: 10.1186/s13046-021-02223-y.
6
Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.泛癌分析 PARP1 改变作为预测免疫治疗效果的生物标志物及其表达水平与免疫治疗特征的关联。
Front Immunol. 2021 Aug 31;12:721030. doi: 10.3389/fimmu.2021.721030. eCollection 2021.
7
Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers.脂肪酸转运和代谢基因的遗传改变与人类癌症的转移进展及不良预后相关。
Sci Rep. 2016 Jan 4;6:18669. doi: 10.1038/srep18669.
8
Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.鉴定SHCBP1作为一种潜在的生物标志物,涉及多种癌症的诊断、预后及肿瘤免疫微环境。
Comput Struct Biotechnol J. 2022 Jun 18;20:3106-3119. doi: 10.1016/j.csbj.2022.06.039. eCollection 2022.
9
Links between autophagy and lipid droplet dynamics.自噬与脂滴动态之间的联系。
J Exp Bot. 2022 May 13;73(9):2848-2858. doi: 10.1093/jxb/erac003.
10
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.癌症驱动基因异柠檬酸脱氢酶1/2(IDH1/2)、含Jumonji结构域的赖氨酸去甲基化酶1C/赖氨酸特异性去甲基化酶5C(JARID1C/KDM5C)以及含泛素羧基末端水解酶结构域的赖氨酸去甲基化酶6A/赖氨酸特异性去甲基化酶6A(UTX/KDM6A):癌症代谢中组蛋白去甲基化与缺氧重编程之间的相互作用
Exp Mol Med. 2019 Jun 20;51(6):1-17. doi: 10.1038/s12276-019-0230-6.

引用本文的文献

1
Trends and hotspots in research related to tumor immune escape: bibliometric analysis and future perspectives.肿瘤免疫逃逸相关研究的趋势与热点:文献计量分析及未来展望
Front Immunol. 2025 Aug 28;16:1604216. doi: 10.3389/fimmu.2025.1604216. eCollection 2025.
2
Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer.具有显著抗肿瘤活性且对肌肉浸润性膀胱癌具有生物安全性的化疗药物二氢杨梅素。
Front Pharmacol. 2025 Jul 18;16:1609354. doi: 10.3389/fphar.2025.1609354. eCollection 2025.
3
WMRCA + : a weighted majority rule-based clustering method for cancer subtype prediction using metabolic gene sets.

本文引用的文献

1
Mapping Multi-factor-mediated Chromatin Interactions to Assess Dysregulation of Lung Cancer-related Genes.绘制多因素介导的染色质相互作用图,以评估肺癌相关基因的失调。
Genomics Proteomics Bioinformatics. 2023 Jun;21(3):573-588. doi: 10.1016/j.gpb.2023.01.004. Epub 2023 Jan 23.
2
Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma.肥胖与透明细胞肾细胞癌中的肾脏脂质代谢异常
Metabolites. 2021 Sep 7;11(9):608. doi: 10.3390/metabo11090608.
3
FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS.
WMRCA + :一种基于加权多数规则的聚类方法,用于使用代谢基因集进行癌症亚型预测。
Hereditas. 2025 Jul 7;162(1):121. doi: 10.1186/s41065-025-00487-4.
4
Reprogramming of fatty acid metabolism in thyroid cancer: Potential targets and mechanisms.甲状腺癌中脂肪酸代谢的重编程:潜在靶点与机制
Chin J Cancer Res. 2025 Apr 30;37(2):227-249. doi: 10.21147/j.issn.1000-9604.2025.02.09.
5
Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center study.揭示载脂蛋白D(APOD)作为胃癌生物标志物的潜力:一项回顾性多中心研究。
Comput Struct Biotechnol J. 2024 Feb 24;23:1051-1064. doi: 10.1016/j.csbj.2024.02.015. eCollection 2024 Dec.
乳腺癌脑转移需要脂肪酸合成。
Nat Cancer. 2021 Apr;2(4):414-428. doi: 10.1038/s43018-021-00183-y. Epub 2021 Apr 1.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis.肿瘤进展和转移过程中癌细胞的代谢重编程
Metabolites. 2021 Jan 2;11(1):28. doi: 10.3390/metabo11010028.
6
Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.代谢物与肿瘤微环境:从细胞机制到全身代谢。
Nat Metab. 2021 Jan;3(1):21-32. doi: 10.1038/s42255-020-00317-z. Epub 2021 Jan 4.
7
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives.癌症的脂质代谢图景与新的治疗前景
Front Oncol. 2020 Dec 8;10:605154. doi: 10.3389/fonc.2020.605154. eCollection 2020.
8
Transcriptomic Data Analyses Reveal a Reprogramed Lipid Metabolism in HCV-Derived Hepatocellular Cancer.转录组数据分析揭示丙型肝炎病毒衍生的肝细胞癌中脂质代谢的重新编程。
Front Cell Dev Biol. 2020 Oct 27;8:581863. doi: 10.3389/fcell.2020.581863. eCollection 2020.
9
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.糖异生酶 PCK1 将 INSIG1/2 磷酸化以进行脂肪生成。
Nature. 2020 Apr;580(7804):530-535. doi: 10.1038/s41586-020-2183-2. Epub 2020 Apr 8.
10
Metabolic reprogramming and cancer progression.代谢重编程与癌症进展。
Science. 2020 Apr 10;368(6487). doi: 10.1126/science.aaw5473.